Laboratorio de Malaria: Parásitos y Vectores, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru.
Instituto de Medicina Tropical "Alexander Von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Sci Rep. 2024 Jul 15;14(1):16291. doi: 10.1038/s41598-024-66925-x.
Hard-to-reach communities represent Peru's main challenge for malaria elimination, but information about transmission in these areas is scarce. Here, we assessed Plasmodium vivax (Pv) and P. falciparum (Pf) transmission dynamics, resistance markers, and Pf hrp2/3 deletions in Nueva Jerusalén (NJ), a remote, indigenous community in the Peruvian Amazon with high population mobility. We collected samples from November 2019 to May 2020 by active (ACD) and passive case detection (PCD) in NJ. Parasites were identified with microscopy and PCR. Then, we analyzed a representative set of positive-PCR samples (Pv = 68, Pf = 58) using highly-multiplexed deep sequencing assays (AmpliSeq) and compared NJ parasites with ones from other remote Peruvian areas using population genetics indexes. The ACD intervention did not reduce malaria cases in the short term, and persistent malaria transmission was observed (at least one Pv infection was detected in 96% of the study days). In Nueva Jerusalen, the Pv population had modest genetic diversity (He = 0.27). Pf population had lower diversity (He = 0.08) and presented temporal clustering, one of these clusters linked to an outbreak in February 2020. Moreover, Pv and Pf parasites from NJ exhibited variable levels of differentiation (Pv Fst = 0.07-0.52 and Pf Fst = 0.11-0.58) with parasites from other remote areas. No artemisin resistance mutations but chloroquine (57%) and sulfadoxine-pyrimethamine (35-67%) were detected in NJ's Pf parasites. Moreover, pfhrp2/3 gene deletions were common (32-50% of parasites with one or both genes deleted). The persistent Pv transmission and the detection of a Pf outbreak with parasites genetically distinct from the local ones highlight the need for tailored interventions focusing on mobility patterns and imported infections in remote areas to eliminate malaria in the Peruvian Amazon.
难以到达的社区是秘鲁消除疟疾的主要挑战,但有关这些地区传播情况的信息很少。在这里,我们评估了新耶路撒冷(NJ)的间日疟原虫(Pv)和恶性疟原虫(Pf)传播动态、耐药标记物以及 Pf hrp2/3 缺失,NJ 是秘鲁亚马逊地区一个偏远的土著社区,人口流动性高。我们于 2019 年 11 月至 2020 年 5 月通过主动(ACD)和被动病例检测(PCD)在 NJ 采集样本。寄生虫通过显微镜和 PCR 鉴定。然后,我们使用高度多重深度测序分析(AmpliSeq)对一组有代表性的阳性-PCR 样本(Pv=68,Pf=58)进行分析,并使用种群遗传学指标将 NJ 寄生虫与其他偏远秘鲁地区的寄生虫进行比较。短期 ACD 干预并没有减少疟疾病例,并且观察到持续的疟疾传播(在研究的至少 96%的时间内检测到至少有一例 Pv 感染)。在新耶路撒冷,Pv 种群的遗传多样性适中(He=0.27)。Pf 种群的遗传多样性较低(He=0.08),且存在时间聚类,其中一个聚类与 2020 年 2 月的一次暴发有关。此外,来自 NJ 的 Pv 和 Pf 寄生虫表现出不同程度的分化(Pv Fst=0.07-0.52,Pf Fst=0.11-0.58),与其他偏远地区的寄生虫不同。在 NJ 的 Pf 寄生虫中没有发现青蒿素耐药突变,但检测到氯喹(57%)和磺胺多辛-乙胺嘧啶(35-67%)耐药。此外,pfhrp2/3 基因缺失很常见(32-50%的寄生虫有一个或两个基因缺失)。持续的 Pv 传播和 Pf 暴发的检测,以及与当地寄生虫遗传上不同的寄生虫,突显了需要针对偏远地区的流动性模式和输入性感染,制定有针对性的干预措施,以消除秘鲁亚马逊地区的疟疾。